• Metformin Tablet

    Free

    Product Composition & Portfolio Range

    We manufacture Metformin SR in the full spectrum of internationally recognized therapeutic strengths, utilizing a specialized slow-release scaffold to reduce dosing frequency to once daily.

    Active Ingredient MonographAvailable StrengthsFormulation Matrix Delivery SystemPrimary Clinical Application
    Metformin Hydrochloride IP / BP / USP500 mgHydrophilic Dual-Polymer Sustained-ReleaseInitial Titration: For low-dose introductory management and early-stage Type 2 stabilization.
    Metformin Hydrochloride IP / BP / USP750 mgHydrophilic Dual-Polymer Sustained-ReleaseIntermediate Scaling: Step-up strength to optimize glycemic indices without increasing tablet count.
    Metformin Hydrochloride IP / BP / USP1000 mgHydrophilic Dual-Polymer Sustained-ReleaseHigh-Potency Maintenance: Maximizes daily therapeutic saturation in an elegant, once-daily single tablet format.